LHC Group (NASDAQ:LHCG) Downgraded to “Buy” at BidaskClub

Share on StockTwits

BidaskClub downgraded shares of LHC Group (NASDAQ:LHCG) from a strong-buy rating to a buy rating in a report issued on Wednesday, BidAskClub reports.

Other research analysts have also issued reports about the company. UBS Group set a $133.00 target price on LHC Group and gave the stock a buy rating in a report on Friday, May 10th. Royal Bank of Canada lifted their target price on NVIDIA to $200.00 and gave the stock an outperform rating in a report on Monday, May 13th. Jefferies Financial Group set a €28.00 ($32.56) target price on Hamburger Hafen und Logistik and gave the stock a buy rating in a report on Thursday, May 9th. Zacks Investment Research lowered Green Plains from a hold rating to a strong sell rating in a report on Thursday, June 27th. Finally, Barclays reiterated a hold rating on shares of LHC Group in a report on Sunday, May 12th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. LHC Group presently has an average rating of Buy and an average price target of $120.58.

NASDAQ:LHCG opened at $122.84 on Wednesday. LHC Group has a 12-month low of $80.84 and a 12-month high of $128.31. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.57 and a quick ratio of 1.57. The company has a market cap of $3.88 billion, a price-to-earnings ratio of 34.60, a P/E/G ratio of 2.10 and a beta of 0.81. The business has a fifty day moving average of $118.49.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.08. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. The business had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. On average, sell-side analysts predict that LHC Group will post 4.3 earnings per share for the current year.

In other LHC Group news, COO Donald Dwayne Stelly sold 448 shares of LHC Group stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $120.00, for a total value of $53,760.00. Following the sale, the chief operating officer now owns 91,252 shares of the company’s stock, valued at approximately $10,950,240. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronald T. Nixon sold 12,000 shares of LHC Group stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $117.20, for a total value of $1,406,400.00. Following the completion of the sale, the director now directly owns 29,100 shares in the company, valued at approximately $3,410,520. The disclosure for this sale can be found here. Insiders sold a total of 46,269 shares of company stock worth $5,314,613 in the last three months. Company insiders own 5.20% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the stock. Parallel Advisors LLC boosted its stake in shares of LHC Group by 790.0% in the first quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock valued at $30,000 after buying an additional 237 shares during the period. Sageworth Trust Co bought a new stake in LHC Group during the first quarter worth $36,000. Quadrant Capital Group LLC lifted its stake in LHC Group by 1,045.7% during the first quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock worth $57,000 after purchasing an additional 481 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in LHC Group during the first quarter worth $68,000. Finally, Private Capital Group LLC lifted its stake in LHC Group by 24.4% during the first quarter. Private Capital Group LLC now owns 1,116 shares of the health services provider’s stock worth $124,000 after purchasing an additional 219 shares during the last quarter. 91.43% of the stock is currently owned by institutional investors and hedge funds.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Recommended Story: How is a Moving Average Calculated?

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.